Drug Development

Dr Ronenn Roubenoff

Working group 1
Novartis Institutes for Biomedical Research
  • Switzerland

Dr. Roubenoff received his MD from Northwestern University, and trained in Internal Medicine and Rheumatology at the Johns Hopkins Hospital, where he was Chief Resident in Medicine. He completed concurrent...

Professor Linda Patridge

Working group 2
Max Plank Institute for Biology of Ageing
  • Germany

Professor Linda Patridge is Honorary Professor at the Faculty of Mathematics and Natural Sciences of the University of Cologne, Germany, Founding Director, Max Planck Institute for Biology of Ageing, Cologne,...

Professor Colin Selman

Working group 3
University of Glasgow
  • United Kingdom

Colin Selman studied for a BSc Zoology (2:1) at the University of Glasgow from 1990-1994. From 1994-1998 he earned a PhD Ecophysiology at the University of Durham. This was followed by post-doctoral researcher positions at...

Professor Kumlesh Dev

Working group 3
Trinity College Dublin
  • Ireland

Kumlesh K. Dev is currently Professor in Neuroscience in the Department of Physiology, a Principal Investigator in the School of Medicine and Director of the M.Sc. Neuroscience programme in Trinity...

Dr Klaus Schughart

Working group 2
Helmholtz Centre for Infection Research
  • Germany

Klaus Schughart is currently Head of Department Infection Genetics at the HZI; professor at the University of Veterinary Medicine, Hannover; visiting professor at the University of Tennessee Health Science Center. Previously...

RSS feed Subscribe to RSS - Drug Development